The strong sales and earnings growth in the first half of the year came from higher demand in the enzyme business and a continued good cost development across the organization. The strong growth was also the result of a challenged first half in 2009. Read the whole company announcement
Increased full-year 2010 expectations after strong first-half performance
| Source: Novonesis (Novozymes A/S)
Pièces jointes
